At OnQuality Pharmaceuticals, we’re designing supportive care treatments aimed at the specific cancer drugs that cause intolerable side effects. We aim to make fighting cancer easier by alleviating the side effects of anti-cancer therapy, so the patients can continue cancer treatment and live with a better quality of life.




What if getting treated for cancer wasn’t such a battle?


According to annual reports of the QuintilesIMS from 2012 to 2017, the market would pay $1 for supportive care for every $4 spent on oncology therapeutic drugs. However, the current pharmaceutical development in cancer therapy is disproportionately focused on oncology therapeutic drugs. We have identified a number of cancer therapy-induced dose-limiting toxicities where treatment gaps exist, and where our approach could be exploited to fill these treatment gaps.